Chronic hepatitis B antigenaemia in patients with hepatosplenic schistosomiasis. 1979

S Bassily, and Z Farid, and G I Higashi, and I A Kamel, and N A El-Masry, and R H Watten

Thirty-five male patients with decompensated hepatosplenic schistosomiasis were longitudinally studied and divided into 3 Groups; with hepatitis B surface antigen (HBsAg) or antibody (anti-HBs) and a control group negative to both. Patients with HBsAg were persistently carrying the antigen as estimated by radioimmunoassay (RIA) for up to 3 years and when compared with the other 2 groups, they had significantly higher serum glutamic transaminases, their liver biopsy showed more destructive liver cell lesions in the form of chronic active hepatitis or liver cirrhosis, they were refractory to diuretic treatment and had higher mortality rate (64% in 3 years compared to 22% and 33% in the other 2 groups). The majority of patients with dual infection are at greater risk in spreading hepatitis B as they proved to carry the 'e' antigen.

UI MeSH Term Description Entries
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008109 Liver Diseases, Parasitic Liver diseases caused by infections with PARASITES, such as tapeworms (CESTODA) and flukes (TREMATODA). Parasitic Liver Diseases,Disease, Parasitic Liver,Diseases, Parasitic Liver,Liver Disease, Parasitic,Parasitic Liver Disease
D008297 Male Males
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006510 Hepatitis B Antibodies Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens. Anti-Australia Antigens,Anti-HBAg,Anti-Hepatitis B Antigens,Anti HBAg,Hepatitis B Virus Antibodies,Anti Australia Antigens,Anti Hepatitis B Antigens,Antibodies, Hepatitis B,Antigens, Anti-Australia,Antigens, Anti-Hepatitis B,B Antibodies, Hepatitis,B Antigens, Anti-Hepatitis,HBAg, Anti
D006514 Hepatitis B Surface Antigens Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen. Australia Antigen,HBsAg,Hepatitis B Surface Antigen,Antigen, Australia
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012552 Schistosomiasis Infection with flukes (trematodes) of the genus SCHISTOSOMA. Three species produce the most frequent clinical diseases: SCHISTOSOMA HAEMATOBIUM (endemic in Africa and the Middle East), SCHISTOSOMA MANSONI (in Egypt, northern and southern Africa, some West Indies islands, northern 2/3 of South America), and SCHISTOSOMA JAPONICUM (in Japan, China, the Philippines, Celebes, Thailand, Laos). S. mansoni is often seen in Puerto Ricans living in the United States. Bilharziasis,Katayama Fever,Schistoma Infection,Bilharziases,Fever, Katayama,Infection, Schistoma,Infections, Schistoma,Schistoma Infections,Schistosomiases
D013158 Splenic Diseases Diseases involving the SPLEEN. Disease, Splenic,Diseases, Splenic,Splenic Disease

Related Publications

S Bassily, and Z Farid, and G I Higashi, and I A Kamel, and N A El-Masry, and R H Watten
January 1990, The Journal of the Egyptian Public Health Association,
S Bassily, and Z Farid, and G I Higashi, and I A Kamel, and N A El-Masry, and R H Watten
January 2000, Revista do Instituto de Medicina Tropical de Sao Paulo,
S Bassily, and Z Farid, and G I Higashi, and I A Kamel, and N A El-Masry, and R H Watten
October 1976, Gastroenterology,
S Bassily, and Z Farid, and G I Higashi, and I A Kamel, and N A El-Masry, and R H Watten
February 1984, East African medical journal,
S Bassily, and Z Farid, and G I Higashi, and I A Kamel, and N A El-Masry, and R H Watten
January 1976, Transactions of the Royal Society of Tropical Medicine and Hygiene,
S Bassily, and Z Farid, and G I Higashi, and I A Kamel, and N A El-Masry, and R H Watten
July 1975, Lancet (London, England),
S Bassily, and Z Farid, and G I Higashi, and I A Kamel, and N A El-Masry, and R H Watten
October 1991, The Tokai journal of experimental and clinical medicine,
S Bassily, and Z Farid, and G I Higashi, and I A Kamel, and N A El-Masry, and R H Watten
January 1987, Revista do Instituto de Medicina Tropical de Sao Paulo,
S Bassily, and Z Farid, and G I Higashi, and I A Kamel, and N A El-Masry, and R H Watten
September 1987, British journal of clinical pharmacology,
S Bassily, and Z Farid, and G I Higashi, and I A Kamel, and N A El-Masry, and R H Watten
January 1971, The American journal of tropical medicine and hygiene,
Copied contents to your clipboard!